On Friday the American Diabetes Association is set to kick of its annual scientific session in San Francisco. Diabetes focused organizations have already begun to make announcements ahead of the show. MobiHealthNews compiled a roundup of the diabetes-related news coming out this week.
GLOOKO, T1D TEAM UP
This morning, diabetes management platform Glooko announced that it is teaming up with...
T1D Exchange, a Boston-based nonprofit that promotes Type 1 diabetes research, has announced the launch of an open online patient data registry. By collecting information from children and adults with the condition, the group hopes to build a substantial longitudinal cohort that will drive new treatment development research and influence new policy or reimbursement decisions.
After creating an...
Diabetes management is a focus area for a number of digital health companies, and increasingly large medical device companies like Medtronic and Dexcom are turning to smartphone apps and connected devices for their consumer offerings. So it’s no surprise that at the 77th Scientific Sessions of the American Diabetes Association, which start today, there is a significant health tech presence.
We...
Novartis and IBM Watson are working together on a new initiative to improve cancer care. In what the pharmaceutical company called a “first-of-its-kind collaboration, the two will use IBM Watson’s cognitive computing tools to leverage Novartis’s portfolio of breast cancer compounds and real-world patient data. The goal is to use data analytics and machine learning to determine which combinations...
StartUp Health, a digital health industry group that incubates companies, connects startups and investors, and tracks funding in the space, has hired a new Chief Financial Officer. Michael Horton, the former managing director of GE Capital, is joining the company.
“Throughout his career, Mike has forged new pathways with wisdom, vision and boundless energy,” Steven Krein, CEO of StartUp Health,...
This week in Paris, companies in the diabetes managment space came together at the Advanced Technologies and Treatments for Diabetes conference to share news and, mostly, a lot of efficacy data. It's an exciting time for the space as closed-loop systems that allow people with diabetes to monitor their glucose continuously and automatically manage their insulin dosing get closer and closer to...
Boston-based nonprofit T1D Exchange has announced its intentions to make a multi-million dollar investment in automated insulin delivery technologies, the smart algorithms that serve as the bridge between CGMs and insulin pumps in the quest to create an artificial pancreas.
“Type 1 diabetes is a disease that, since the invention of artificial insulin back in 1921, still plagues us because...
